Cannara Biotech Inc. (TSXV: LOVE)

Canada flag Canada · Delayed Price · Currency is CAD
0.670
+0.080 (13.56%)
Nov 20, 2024, 3:46 PM EST
-27.96%
Market Cap 60.31M
Revenue (ttm) 76.69M
Net Income (ttm) 5.32M
Shares Out 90.02M
EPS (ttm) 0.06
PE Ratio 11.37
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 27,160
Open 0.650
Previous Close 0.590
Day's Range 0.650 - 0.670
52-Week Range 0.520 - 1.040
Beta 1.08
Analysts n/a
Price Target n/a
Earnings Date Nov 29, 2024

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]

Sector Healthcare
Founded 2017
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol LOVE
Full Company Profile

Financial Performance

In 2023, Cannara Biotech's revenue was 57.26 million, an increase of 59.76% compared to the previous year's 35.84 million. Earnings were 6.95 million, an increase of 201.26%.

Financial Statements

News

There is no news available yet.